Objective: To estimate incidence and lifetime risk of diagnosed symptomatic knee OA and age of diagnosis of knee OA based on self-reports in the US population.
SIGNIFICANCE AND INNOVATIONS
• We provide estimates of the incidence of diagnosed symptomatic knee OA in the US using population-based national data from 2007-2008.
• The estimated mean and median age of diagnosis of symptomatic knee OA was 55 years.
• With half of cases of symptomatic knee OA diagnosed by age 55, the burden of future healthcare utilization for knee OA may be high.
INTRODUCTION
Knee osteoarthritis (OA) is a painful, disabling condition that affects an estimated 9.3 million US adults. 1 Because no disease-modifying treatments are available, treatments for symptomatic knee OA focus on symptom relief and functional restoration, including physical therapy, medications, joint injections, and total knee replacement. [2] [3] [4] [5] For decades, knee OA had been viewed as a disease mostly affecting older persons.
However, recent evidence documents increased incidence of two key risk factors for knee OA -traumatic knee injury 6 and obesity, 7, 8 particularly in younger persons.
9, 10
Evolving data point to high prevalence of posttraumatic knee OA in younger persons.
11-
13 This trend and the increasing prevalence of obesity among children are likely to lead to increased rates of osteoarthritis in young adults.
14 Most population-based data on knee OA prevalence and incidence refer to studies conducted in the mid-1990s. [15] [16] [17] In fact, the two most recent studies reporting incidence of symptomatic knee OA in the US were published 17 years ago in 1995. 15, 16 Furthermore, although obesity is a known risk factor, no studies have reported age-and sex-specific knee OA incidence separately for obese and non-obese persons.
Determining the age of diagnosis of symptomatic knee OA is critical to understanding the trajectory of decrements in quality of life and utilization of health services.
We sought to use national self-reported data to derive current age-, sex-, and obesitystratified estimates of the incidence of diagnosed symptomatic knee OA, to estimate the mean and median age of diagnosis, and to estimate the lifetime risk of diagnosis among 25 year olds representative of the US population.
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MATERIALS AND METHODS
Analytic overview
The incidence of diagnosed symptomatic knee OA was derived as a ratio of disease prevalence odds to disease duration (see Technical Appendix for a more detailed explanation of incidence calculations). 18 We used self-reported data from the 2007-2008 NHIS to estimate the prevalence of diagnosed symptomatic knee OA.
19 Disease duration was derived using the Osteoarthritis Policy (OAPol) Model, a published and validated computer simulation model of knee OA natural history and management.
20, 21
Incidence was estimated within 10-year age groups and was further stratified by sex and obesity status.
We then used the OAPol Model and our newly derived incidence estimates to determine mean and median ages of diagnosis of symptomatic knee OA in the US. To model disease duration, cohorts were initialized with knee OA, and the output of interest was life expectancy. To model age of diagnosis, cohorts were initialized without knee OA, and the output of interest was the development of OA, or cumulative incidence of OA.
OAPol Model
The These reduced prevalence data and 95% CIs were used as benchmarks for the calibration of OA incidence.
Estimating incidence of diagnosed symptomatic knee OA
We estimated the incidence rates of diagnosed symptomatic knee OA as a ratio of the 
Estimating lifetime risk of diagnosed symptomatic knee OA and average age at diagnosis
Using the OAPol Model and our calculated incidence rates, we estimated lifetime risk of diagnosed symptomatic knee OA from age 25, defined as the cumulative probability of being diagnosed with symptomatic knee OA over the lifetime for US adults in each of the five cohorts described below. The lifetime risk was calculated by dividing the cumulative number of incident cases of diagnosed symptomatic knee OA within each cohort predicted by the OAPol Model by the size of the initial population at risk for the disease reported by US Census data. We used the OAPol Model to estimate the mean and median age of symptomatic knee OA diagnosis using the derived incidence rates. Mean age was obtained by constructing a distribution by age of all incident cases of diagnosed symptomatic knee OA based on the OAPol Model and calculating a mean of this distribution. Median age represented the age at which 50% of those ultimately diagnosed with symptomatic knee OA had been diagnosed (i.e. the 50% mark of the cumulative distribution function of incident cases). Mean age is reported to one tenth of a year; median age is reported as an integer.
Populations under consideration
Using the OAPol Model, we simulated five cohorts that were followed from age 25 until death: 1) non-obese females; 2) obese females; 3) non-obese males; 4) obese males; 
RESULTS
Estimated prevalence of diagnosed symptomatic knee OA
Age-, sex-, and obesity-stratified estimates of the prevalence of diagnosed symptomatic knee OA are presented in Table 2 . For non-obese males, the estimated prevalence ranged from 0.74% among those aged 25 to 34 to 12.94% in those older than 85 years.
For non-obese females, estimated prevalence ranged from 0.88% for the youngest age group (25 to 34 years) to 14.97% among those older than 85 years of age. For obese males, the estimated prevalence ranged from 1.54% in the youngest group to 23.54% in the oldest group. Obese females had the highest estimated prevalence ranging from 2.41% for the youngest group to 32.45% in the oldest age group. Estimated annual incidences of diagnosed symptomatic knee OA, stratified by age, sex, and obesity, are presented in Table 2 . Estimated incidence ranged from 0.12% per year in the youngest non-obese males to 1.02% per year in obese females aged 55 to 64 years. For all sex and obesity status combinations, incidence peaked at ages 55 to 64
and was lowest among those older than age 85. For non-obese males, incidence ranged from 0.04% to 0.37% per year. For non-obese females, incidence ranged from 0.06% to 0.43% per year. Among obese males, incidence ranged from 0.05% per year to 0.64% per year. For obese females, incidence ranged from 0.10% to 1.02% per year.
Results of the internal validation analysis using our current incidence estimates are presented in Figure 1 . Within each 10-year age group, the model-based prevalence estimates fell within the 95% CI of the NHIS data for each cohort, defined by sex and obesity status.
Estimated age of diagnosis of symptomatic knee OA
Using current demographic, obesity, and comorbidity profiles representative of the general population in the US, the estimated mean age of symptomatic knee OA diagnosis was 53.5 (SD = 14.4). The estimated median age of diagnosis of symptomatic knee OA was 55 years (Figure 2 ).
Lifetime risk of diagnosed symptomatic knee OA
The lifetime risk of diagnosed symptomatic knee OA from age 25 in the US population was estimated at 13.8%, with a 9.3% risk of having diagnosed symptomatic knee OA by age 60 (Figure 3 Our estimates also provide insight into the differential impact of obesity on diagnosed OA incidence across age and sex strata. A recent study from the Johnston County
Osteoarthritis Project in North Carolina found that lifetime risk of symptomatic knee OA from age 45 was nearly 45%, 33 considerably greater than our estimate of 16%. Several differences in study design and population may explain this difference. First, the Johnston County study utilized radiographs to define symptomatic knee OA.
Unpublished data from the Johnston County Osteoarthritis Project indicate that only about 2/3 of those identified as having symptomatic knee OA reported being diagnosed with OA by a health professional. Second, the current study projected lifetime risk from an earlier age (25 years), while the Johnston County study estimated lifetime risk from age 45. 33 Third, differences between the study populations in Johnston County and the NHIS may also account for some of the differences in estimated lifetime risk. The estimated rates of diagnosed knee OA incidence differ somewhat from prior studies published 10-20 years ago. The study by Oliveria et al, published in 1995 based on the data from a Fallon health plan, used medical records to estimate annual incidence of diagnosed knee OA. Authors found that incidence of diagnosed symptomatic knee OA increases with increasing age until age 80).16
Earlier peak of incidence estimated in our study is consistent with the trend of earlier diagnosis and earlier use of TKR.
Our estimates suggest that persons aged 55 to 64 today are at highest risk for a new diagnosis of symptomatic knee OA, with incidence of diagnosed disease tapering off in older ages. If these differences are indicative of secular trends, they may reflect increased likelihood of diagnosis earlier in life rather than earlier onset of biological
disease. An increase in the rate of diagnosed cases could result from increased patient awareness of knee OA, as well as a heightened inclination to diagnose knee OA on the part of physicians. Because rigorous comparisons between our findings and the study by Oliveria and colleagues are limited by methodological differences and heterogeneity in the study populations, further research is needed to understand secular trends in the diagnosis and incidence of symptomatic knee OA.
Our findings have important implications for disease prevention and health care utilization. The early median age of diagnosis of symptomatic knee OA (55 years)
suggests that public health officials should introduce prevention strategies relatively early in the life course. Policymakers should implement prevention strategies aimed at reducing obesity and the risk of knee injury, two major risk factors for knee OA.
Furthermore, the early age of diagnosis of symptomatic knee OA may yield high levels of lifetime health care utilization and costs. In the last decade, the mean age of total knee replacement (TKR) has decreased from 69 to 66 years and utilization of TKR has tripled among US adults aged 45 to 64. 34 Whether health outcomes improve as a result of early diagnosis of symptomatic knee OA offers a rich area for future research.
The results from this study should be viewed within the context of certain assumptions and limitations in our approach. First, the definition of OA poses challenges. Furthermore, the sample size and national scope of the NHIS offer advantages over smaller, geographically-limited observational studies. Second, we assumed constant annual incidence of symptomatic knee OA within 10-year age strata. While a more precise method might have captured a smoother age distribution, incidence of the disease is unlikely to differ enough across any 10-year age group to have a meaningful effect on our estimates.
Our estimates suggest that diagnosis of symptomatic knee OA occurs early in the life course (median age 55 years), with incidence peaking between ages 55 and 64. Early diagnosis of symptomatic knee OA may yield future increases in health care utilization and medical costs associated with knee OA. Physicians and policymakers can use our findings to direct resources toward preventing risk factors for knee OA. Policymakers The black curve is cumulative incidence using current incidence estimates. The vertical dashed line denotes the median age of diagnosis (i.e. the age by which 50% of cases have been diagnosed). The patterned dark gray curve represents the overall cumulative incidence of diagnosed symptomatic knee OA from age 25. Dashed curves represent cumulative incidence among non-obese persons; solid curves represent cumulative incidence among obese persons. Female cumulative incidence is in black; male cumulative incidence is in light 
